HROW Harrow, Inc.

30.41USD-5.35%Mkt Cap: 1.14B USDP/E: —

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segment…